HEPATITIS-B VIRUS PRECORE MUTANT INFECTION IS ASSOCIATED WITH SEVERE RECURRENT DISEASE AFTER LIVER-TRANSPLANTATION

被引:11
作者
ANGUS, PW
LOCARNINI, SA
MCCAUGHAN, GW
JONES, RM
MCMILLAN, JS
BOWDEN, DS
机构
[1] FAIRFIELD HOSP,VICTORIAN INFECT DIS REFERENCE LAB,FAIRFIELD,VIC 3078,AUSTRALIA
[2] ROYAL PRINCE ALFRED HOSP,LIVER TRANSPLANT UNIT,CAMPERDOWN,NSW,AUSTRALIA
关键词
D O I
10.1002/hep.1840210104
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The factors that predispose patients undergoing liver transplantation for hepatitis B virus (HBV) disease to severe recurrence of infection are unclear. In this study we examined the effect of pretransplantation infection with HBV and precore variant strains of HBV on posttransplantation outcome and allograft histology in 24 patients who survived more than 3 months after liver transplantation. Based on pretransplantation serum HBV DNA status as detected by the polymerase chain reaction (PCR) and direct sequencing, the 24 patients could be assigned to three groups. In group 1 there were 4 patients HBV DNA-negative before transplantation and none of these patients suffered recurrence of infection posttransplantation. In group 2, of 10 patients with pretransplantation infection with wild-type virus, 7 became reinfected, and 1 of these developed HBV-related graft failure, In group 3, 9 of 10 patients infected with precore mutant HBV strains became reinfected, However, in contrast to the patients in group 2, 7 patients in group 3 developed HBV-related graft loss, and 5 of these patients had fibrosing cholestatic hepatitis (FCH). These results indicate that infection with precore mutant strains of HBV predisposes a patient to early graft loss following transplantation.
引用
收藏
页码:14 / 18
页数:5
相关论文
共 30 条
[1]   COMBINATION ANTIVIRAL THERAPY CONTROLS SEVERE POST-LIVER TRANSPLANT RECURRENCE OF HEPATITIS-B VIRUS-INFECTION [J].
ANGUS, P ;
RICHARDS, M ;
BOWDEN, S ;
IRETON, J ;
SINCLAIR, R ;
JONES, R ;
LOCARNINI, S .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1993, 8 (04) :353-357
[2]   HEPATITIS-B VIRUS HETEROGENEITY, ONE OF MANY FACTORS INFLUENCING THE SEVERITY OF HEPATITIS-B [J].
BONINO, F ;
BRUNETTO, MR .
JOURNAL OF HEPATOLOGY, 1993, 18 (01) :5-8
[3]   NATURAL COURSE AND RESPONSE TO INTERFERON OF CHRONIC HEPATITIS-B ACCOMPANIED BY ANTIBODY TO HEPATITIS-B-E ANTIGEN [J].
BRUNETTO, MR ;
OLIVERI, F ;
ROCCA, G ;
CRISCUOLO, D ;
CHIABERGE, E ;
CAPALBO, M ;
DAVID, E ;
VERME, G ;
BONINO, F .
HEPATOLOGY, 1989, 10 (02) :198-202
[4]   LIVER-TRANSPLANTATION TODAY [J].
BUSUTTIL, RW ;
GOLDSTEIN, LI ;
DANOVITCH, GM ;
AMENT, ME ;
MEMSIC, LDF .
ANNALS OF INTERNAL MEDICINE, 1986, 104 (03) :377-389
[5]  
CALMUS Y, 1990, TRANSPLANT P, V22, P2311
[6]   GENETIC-VARIATION IN HEPATITIS-B-VIRUS [J].
CARMAN, WF ;
THOMAS, HC .
GASTROENTEROLOGY, 1992, 102 (02) :711-719
[7]  
COTE PJ, 1991, J IMMUNOL, V146, P3138
[8]   HEPATIC HISTOLOGICAL-FINDINGS AFTER TRANSPLANTATION FOR CHRONIC HEPATITIS-B VIRUS-INFECTION, INCLUDING A UNIQUE PATTERN OF FIBROSING CHOLESTATIC HEPATITIS [J].
DAVIES, SE ;
PORTMANN, BC ;
OGRADY, JG ;
ALDIS, PM ;
CHAGGAR, K ;
ALEXANDER, GJM ;
WILLIAMS, R .
HEPATOLOGY, 1991, 13 (01) :150-157
[9]  
DEMETRIS AJ, 1990, AM J PATHOL, V137, P667
[10]   FIBROSING CHOLESTATIC HEPATITIS IN A TRANSPLANT RECIPIENT WITH HEPATITIS-B VIRUS PRECORE MUTANT [J].
FANG, JWS ;
TUNG, FYT ;
DAVIS, GL ;
DOLSON, DJ ;
VANTHIEL, DH ;
LAU, JYN .
GASTROENTEROLOGY, 1993, 105 (03) :901-904